{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:27:41Z","timestamp":1786505261581,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As the global demand for hip and knee arthroplasty procedures grow, advancements in orthopedic research are vital for progress. Pilot and feasibility trials play a critical role in optimising research efficiency, highlighting methodological gaps, and maximising study insights. However, the completeness of reporting in hip and knee arthroplasty pilot and feasibility trials remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The primary objective was to evaluate reporting completeness, assessed using the CONSORT checklist extension to pilot and feasibility trials. Secondary objectives included evaluating the reporting of key feasibility items and exploring factors associated with reporting completeness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting and methods<\/jats:title>\n                    <jats:p>This methodological survey analysed pilot and feasibility trials in hip and knee arthroplasty. A PubMed search identified relevant manuscripts published between January 1, 2017, and December 31, 2023. A minimum acceptable sample size of 147 (of 278 eligible) was identified, based on a calculation involving an estimated reporting completeness of 25% of the CONSORT checklist, a 95% confidence interval, and a 5% margin of error. Descriptive statistics were reported, and a multivariable linear regression with robust (HC1) standard errors was completed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 278 eligible publications identified from PubMed, a random sample of 147 studies was included. Reporting completeness was low, with studies accounting for a mean of 54.98% (16.95) of applicable CONSORT extension items. Notably, pilot-specific objectives and future study implications were often underreported. Similarly, manuscripts missed approximately 71.35% (10\/14) of key feasibility elements. Studies that referenced reporting guidelines in the manuscript text were associated with better reporting, while those that failed to disclose their funding sources and lacked more key feasibility items demonstrated weaker reporting completeness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hip and knee arthroplasty pilot and feasibility trials exhibit suboptimal reporting completeness with several missing feasibility elements. Improved adherence to CONSORT guidelines and enhanced transparency are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40814-026-01859-x","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:33:49Z","timestamp":1780540429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The reporting of CONSORT items and key feasibility elements in pilot and feasibility studies in hip and knee arthroplasty is suboptimal: a methodological survey"],"prefix":"10.1186","volume":"12","author":[{"given":"Zinnia","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh-Ann","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Mbuagbaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipalo","family":"Mokete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9034-0021","authenticated-orcid":false,"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"6","key":"1859_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.4097\/kjae.2017.70.6.601","volume":"70","author":"J In","year":"2017","unstructured":"In J. Introduction of a pilot study. Korean J Anesthesiol. 2017;70(6):601\u20135. https:\/\/doi.org\/10.4097\/kjae.2017.70.6.601.","journal-title":"Korean J Anesthesiol"},{"issue":"40","key":"1859_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7748\/ns2002.06.16.40.33.c3214","volume":"16","author":"E van Teijlingen","year":"2002","unstructured":"van Teijlingen E, Hundley V. The importance of pilot studies. Nurs Stand. 2002;16(40):33\u20136. https:\/\/doi.org\/10.7748\/ns2002.06.16.40.33.c3214.","journal-title":"Nurs Stand"},{"key":"1859_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-117","volume":"11","author":"M Shanyinde","year":"2011","unstructured":"Shanyinde M, Pickering RM, Weatherall M. Questions asked and answered in pilot and feasibility randomized controlled trials. BMC Med Res Methodol. 2011;11:117. https:\/\/doi.org\/10.1186\/1471-2288-11-117.","journal-title":"BMC Med Res Methodol"},{"key":"1859_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-019-0499-1","author":"GA Lancaster","year":"2019","unstructured":"Lancaster GA, Thabane L. Guidelines for reporting non-randomised pilot and feasibility studies. Pilot and Feasibility Studies. 2019. https:\/\/doi.org\/10.1186\/s40814-019-0499-1.","journal-title":"Pilot and Feasibility Studies"},{"issue":"9","key":"1859_CR5","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1177\/0269215517692129","volume":"31","author":"N Kaur","year":"2017","unstructured":"Kaur N, Figueiredo S, Bouchard V, Moriello C, Mayo N. Where have all the pilot studies gone? A follow-up on 30 years of pilot studies in Clinical Rehabilitation. Clin Rehabil. 2017;31(9):1238\u201348. https:\/\/doi.org\/10.1177\/0269215517692129.","journal-title":"Clin Rehabil"},{"issue":"15","key":"1859_CR6","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/jama.2015.10962","volume":"314","author":"C Kistin","year":"2015","unstructured":"Kistin C, Silverstein M. Pilot studies: a critical but potentially misused component of interventional research. JAMA. 2015;314(15):1561\u20132. https:\/\/doi.org\/10.1001\/jama.2015.10962.","journal-title":"JAMA"},{"key":"1859_CR7","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.17.00015","author":"R Moyer","year":"2017","unstructured":"Moyer R, Ikert K, Long K, Marsh J. The value of preoperative exercise and education for patients undergoing total hip and knee arthroplasty: a systematic review and meta-analysis. JBJS Reviews. 2017. https:\/\/doi.org\/10.2106\/JBJS.RVW.17.00015.","journal-title":"JBJS Reviews"},{"issue":"1","key":"1859_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s40409-018-0142-2","volume":"24","author":"LPF Abbade","year":"2018","unstructured":"Abbade LPF, Abbade JF, Thabane L. Introducing the CONSORT extension to pilot trials: enhancing the design, conduct and reporting of pilot or feasibility trials. J Venom Anim Toxins Incl Trop Dis. 2018;24(1):4. https:\/\/doi.org\/10.1186\/s40409-018-0142-2.","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"1859_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5239","volume":"355","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:5239. https:\/\/doi.org\/10.1136\/bmj.i5239.","journal-title":"BMJ"},{"issue":"1","key":"1859_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5435\/JAAOS-D-17-00709","volume":"27","author":"AJ Schwartz","year":"2019","unstructured":"Schwartz AJ, Bozic KJ, Etzioni DA. Value-based total hip and knee arthroplasty: a framework for understanding the literature. J Am Acad Orthop Surg. 2019;27(1):1\u201311. https:\/\/doi.org\/10.5435\/JAAOS-D-17-00709.","journal-title":"J Am Acad Orthop Surg"},{"key":"1859_CR11","unstructured":"Hip and knee replacements in Canada: CJRR annual ... Accessed October 1, 2024. https:\/\/www.cihi.ca\/sites\/default\/files\/document\/hip-knee-replacements-in-canada-cjrr-annual-report-2021-2022-en.pdf."},{"key":"1859_CR12","volume":"154","author":"R Otten","year":"2010","unstructured":"Otten R, van Roermund PM, Picavet HS. Trends in aantallen knie- en heupartroplastieken: de vraag naar knie- en heupprotheses blijft voorlopig toenemen [Trends in the number of knee and hip arthroplasties: considerably more knee and hip prostheses due to osteoarthritis in 2030]. Ned Tijdschr Geneeskd. 2010;154:A1534.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"10","key":"1859_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-085441","volume":"14","author":"Z Chung","year":"2024","unstructured":"Chung Z, Mbuagbaw L, Mokete L, Bhandari M, Thabane L. Quality and completeness of, and spin in reporting of, pilot and feasibility studies in hip and knee arthroplasty: a protocol for a methodological survey. BMJ Open. 2024;14(10):e085441. https:\/\/doi.org\/10.1136\/bmjopen-2024-085441. (Published 2024 Oct 8).","journal-title":"BMJ Open"},{"issue":"1","key":"1859_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-018-0302-8","volume":"4","author":"GC Isiguzo","year":"2018","unstructured":"Isiguzo GC, Zunza M, Chirehwa M, Mayosi BM, Thabane L. Quality of pilot trial abstracts in heart failure is suboptimal: a systematic survey. Pilot Feasibility Stud. 2018;4(1):107. https:\/\/doi.org\/10.1186\/s40814-018-0302-8.","journal-title":"Pilot Feasibility Stud"},{"issue":"4","key":"1859_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040770","volume":"8","author":"VD Ngah","year":"2020","unstructured":"Ngah VD, Mazingisa AV, Zunza M, Wiysonge CS. A review of adherence and predictors of adherence to the CONSORT Statement in the reporting of tuberculosis vaccine trials. Vaccines. 2020;8(4):770. https:\/\/doi.org\/10.3390\/vaccines8040770.","journal-title":"Vaccines"},{"issue":"1","key":"1859_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3868-4","volume":"20","author":"V Mozetic","year":"2019","unstructured":"Mozetic V, Leonel L, Leite Pacheco R, et al. Reporting quality and adherence of randomized controlled trials about statins and\/or fibrates for diabetic retinopathy to the CONSORT checklist. Trials. 2019;20(1):729. https:\/\/doi.org\/10.1186\/s13063-019-3868-4. (Published 2019 Dec 16).","journal-title":"Trials"},{"issue":"9","key":"1859_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257093","volume":"16","author":"Y Yin","year":"2021","unstructured":"Yin Y, Shi F, Zhang Y, Zhang X, Ye J, Zhang J. Evaluation of reporting quality of randomized controlled trials in patients with COVID-19 using the CONSORT statement. PLoS ONE. 2021;16(9):e0257093. https:\/\/doi.org\/10.1371\/journal.pone.0257093. (Published 2021 Sep 23).","journal-title":"PLoS ONE"},{"issue":"4","key":"1859_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0197-2456(02)00214-3.","volume":"23","author":"PJ Devereaux","year":"2002","unstructured":"Devereaux PJ, Manns BJ, Ghali WA, Quan H, Guyatt GH. The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials. 2002;23(4):380\u20138. https:\/\/doi.org\/10.1016\/S0197-2456(02)00214-3.","journal-title":"Control Clin Trials"},{"issue":"3","key":"1859_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276\u201382.","journal-title":"Biochem Med (Zagreb)"},{"key":"1859_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111335","volume":"170","author":"T McKechnie","year":"2024","unstructured":"McKechnie T, Kazi T, Wang A, et al. Pilot and feasibility trials in surgery are incompletely reported according to the CONSORT checklist: a meta-research study. J Clin Epidemiol. 2024;170:e 111335. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111335. (Published 27 March 2024.).","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1859_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jpurol.2021.09.012","volume":"17","author":"M McGrath","year":"2021","unstructured":"McGrath M, Chen C, Braga LH, et al. Quality of reporting for pilot randomized controlled trials in the pediatric urology literature\u2013A systematic review. J Pediatr Urol. 2021;17(6):846\u201354. https:\/\/doi.org\/10.1016\/j.jpurol.2021.09.012. (Published 2021 Deceomber.).","journal-title":"J Pediatr Urol"},{"issue":"3","key":"1859_CR22","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.95415","volume":"17","author":"A Ghasemi","year":"2019","unstructured":"Ghasemi A, Bahadoran Z, Mirmiran P, Hosseinpanah F, Shiva N, Zadeh-Vakili A. The principles of biomedical scientific writing: discussion. Int J Endocrinol Metab. 2019;17(3):e95415. https:\/\/doi.org\/10.5812\/ijem.95415. (Published 2019 Jul 29.).","journal-title":"Int J Endocrinol Metab"},{"issue":"1","key":"1859_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-11-32","volume":"11","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11(1):32. https:\/\/doi.org\/10.1186\/1745-6215-11-32.","journal-title":"Trials"},{"key":"1859_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527. https:\/\/doi.org\/10.1136\/bmj.h5527. (Published 2015 Oct 28.).","journal-title":"BMJ"},{"key":"1859_CR25","doi-asserted-by":"publisher","unstructured":"Bhatt, M., Zielinski, L., Sanger, N. et al. Evaluating Completeness of Reporting in Behavioral Interventions Pilot Trials: A Systematic Survey. Res. Soc. Work Pract. 2017. 28(5), 577\u2013584. Published 23 July 2017. https:\/\/doi.org\/10.1177\/1049731517720033","DOI":"10.1177\/1049731517720033"},{"issue":"1","key":"1859_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-67","volume":"10","author":"M Arain","year":"2010","unstructured":"Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010;10(1):67. https:\/\/doi.org\/10.1186\/1471-2288-10-67.","journal-title":"BMC Med Res Methodol"},{"issue":"13","key":"1859_CR27","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1161\/CIRCULATIONAHA.109.861625","volume":"119","author":"J Loscalzo","year":"2009","unstructured":"Loscalzo J. Pilot trials in clinical research: of what value are they? Circulation. 2009;119(13):1694\u20136. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.861625.","journal-title":"Circulation"},{"issue":"2","key":"1859_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cct.2014.05.012","volume":"38","author":"L Mbuagbaw","year":"2014","unstructured":"Mbuagbaw L, Thabane M, Vanniyasingam T, et al. Improvement in the quality of abstracts in major clinical journals since CONSORT extension for abstracts: a systematic review. Contemp Clin Trials. 2014;38(2):245\u201350. https:\/\/doi.org\/10.1016\/j.cct.2014.05.012.","journal-title":"Contemp Clin Trials"},{"key":"1859_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jclinepi.2022.12.019","volume":"154","author":"J Helbach","year":"2023","unstructured":"Helbach J, Hoffmann F, Pieper D, Allers K. Reporting according to the preferred reporting items for systematic reviews and meta-analyses for abstracts (PRISMA-A) depends on abstract length. J Clin Epidemiol. 2023;154:167\u201377. https:\/\/doi.org\/10.1016\/j.jclinepi.2022.12.019.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"1859_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/jama.280.3.269","volume":"280","author":"RW Scherer","year":"1998","unstructured":"Scherer RW, Crawley B. Reporting of randomized clinical trial descriptors and use of structured abstracts. JAMA. 1998;280(3):269\u201372. https:\/\/doi.org\/10.1001\/jama.280.3.269. ([published correction appears in JAMA 1998 Sep 23-30;280(12):1054]).","journal-title":"JAMA"},{"key":"1859_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-023-02235-z","volume":"12","author":"AA Veroniki","year":"2023","unstructured":"Veroniki AA, Wong EKC, Lunny C, et al. Does type of funding affect reporting in network meta-analysis? A scoping review of network meta-analyses. Syst Rev. 2023;12:81. https:\/\/doi.org\/10.1186\/s13643-023-02235-z. (Published 06 May 2023.).","journal-title":"Syst Rev"},{"issue":"6","key":"1859_CR32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/archotol.131.6.479","volume":"131","author":"CD DeAngelis","year":"2005","unstructured":"DeAngelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Arch Otolaryngol Head Neck Surg. 2005;131(6):479\u201380. https:\/\/doi.org\/10.1001\/archotol.131.6.479.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"1859_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4212\/cjhp.v68i1.1422","volume":"68","author":"S Houle","year":"2015","unstructured":"Houle S. An introduction to the fundamentals of randomized controlled trials in pharmacy research. Can J Hosp Pharm. 2015;68(1):28\u201332. https:\/\/doi.org\/10.4212\/cjhp.v68i1.1422.","journal-title":"Can J Hosp Pharm"},{"issue":"4","key":"1859_CR34","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/aogs.13309","volume":"97","author":"A Bhide","year":"2018","unstructured":"Bhide A, Shah PS, Acharya G. A simplified guide to randomized controlled trials. Acta Obstet Gynecol Scand. 2018;97(4):380\u20137. https:\/\/doi.org\/10.1111\/aogs.13309.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"1859_CR35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/1744987119883404","volume":"25","author":"T Mailhot","year":"2020","unstructured":"Mailhot T, Goulet MH, Maheu-Cadotte MA, Fontaine G, Lequin P, Lavoie P. Methodological reporting in feasibility studies: a descriptive review of the nursing intervention research literature. J Res Nurs. 2020;25(5):460\u201372. https:\/\/doi.org\/10.1177\/1744987119883404.","journal-title":"J Res Nurs"},{"issue":"7","key":"1859_CR36","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.ejso.2022.04.012","volume":"48","author":"ACM Cuijpers","year":"2022","unstructured":"Cuijpers ACM, Linskens FG, Bongers BC, Stassen LPS, Lubbers T, van Meeteren NLU. Quality and clinical generalizability of feasibility outcomes in exercise prehabilitation before colorectal cancer surgery - a systematic review. Eur J Surg Oncol. 2022;48(7):1483\u201397. https:\/\/doi.org\/10.1016\/j.ejso.2022.04.012.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"1859_CR37","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.OA.22.00112","volume":"8","author":"I Shichman","year":"2023","unstructured":"Shichman I, Roof M, Askew N, et al. Projections and epidemiology of primary hip and knee arthroplasty in Medicare patients to 2040-2060. JB JS Open Access. 2023;8(1):e22.00112. https:\/\/doi.org\/10.2106\/JBJS.OA.22.00112. (Published 2023 Feb 28.).","journal-title":"JB JS Open Access"},{"issue":"5","key":"1859_CR38","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/1120700018757940","volume":"28","author":"C Pabinger","year":"2018","unstructured":"Pabinger C, Lothaller H, Portner N, Geissler A. Projections of hip arthroplasty in OECD countries up to 2050. Hip Int. 2018;28(5):498\u2013506. https:\/\/doi.org\/10.1177\/1120700018757940.","journal-title":"Hip Int"},{"key":"1859_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-1-60","volume":"1","author":"L Turner","year":"2012","unstructured":"Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012;1:60. https:\/\/doi.org\/10.1186\/2046-4053-1-60. (Published 2012 Nov 29).","journal-title":"Syst Rev"},{"issue":"1","key":"1859_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-020-00634-w","volume":"6","author":"N Pearson","year":"2020","unstructured":"Pearson N, Naylor PJ, Ashe MC, Fernandez M, Yoong SL, Wolfenden L. Guidance for conducting feasibility and pilot studies for implementation trials. Pilot Feasibility Stud. 2020;6(1):167. https:\/\/doi.org\/10.1186\/s40814-020-00634-w. (Published 2020 Oct 31).","journal-title":"Pilot Feasibility Stud"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-026-01859-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-026-01859-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-026-01859-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:45:35Z","timestamp":1786502735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40814-026-01859-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1859"],"URL":"https:\/\/doi.org\/10.1186\/s40814-026-01859-x","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This methodological review did not require ethical approval. In line with TCPS 2, articles 2.2\u20132.4, the study only utilised published, peer-reviewed, and publicly available literature. No personal identifiers linked to individuals were included.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors of the manuscript have read and agreed to the terms of the BioMed Central Copyright and License Agreement. The authors confirm that this is an original article and has not been published nor is under consideration for publication with another journal. All authors agree to maintain accountability for all aspects of the accuracy and integrity of the manuscript in accordance with ICMJE criteria.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and understood the journal\u2019s policy on declaration of interests and have nothing to declare.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"114"}}